COMPOSITION FOR USE DURING ANGIOGENESIS AUGMENTATION IN INTESTINE, NUTRIENT ABSORPTION AND TOLERANCE TO ENTERAL NUTRITION, AND/OR DURING PREVENTION AND/OR TREATMENT OF INFLAMMATORY INTESTINE DISEASES, AND/OR DURING RECOVERY FROM INTESTINE INJURY AND SURGICAL INTERVENTION Russian patent published in 2017 - IPC A61K31/202 A23D9/00 A61K35/741 A61K31/702 A61P1/00 A61P1/14 

FIELD: pharmacology.

SUBSTANCE: composition comprising at least one longchain polyunsaturated fatty acid (LC-PUFA), at least one probiotic and a mixture of oligosaccharides comprising at least one N-acetylated oligosaccharide, at least one sialylated oligosaccharide and at least one neutral oligosaccharide for angiogenesis augmentation in intestine and nutrient absorption, tolerance to enteral nutrition of suckling children or growing infants; its use as a synthetic nutrient agent for the same purpose; composition of the same formulation used during prevention and/or treatment of inflammatory intestine diseases, representing necrotizing enterocolitis, and/or during recovery from injury and/or surgical intervention in the intestine area of suckling children or growing infants, and its use as a synthetic nutrient agent for the same purpose are proposed.

EFFECT: angiogenesis augmentation in intestine, which enables to reduce the risk of necrotizing enterocolitis and facilitates recovery from injury or surgical intervention in intestine of suckling children or growing infants.

26 cl, 4 dwg, 4 tbl